Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia.
Subacute stent thrombosis occurred in a patient 34 days after receiving a heparin-coated (HC) stent. The patient developed heparin-induced thrombocytopenia and diffuse thrombosis after the stent was placed. This raises the concern that patients who develop heparin-associated antibodies in the context of a recently placed HC stent may have an increased risk for subacute stent thrombosis.
Cruz
Daniel
D
Department of Cardiology, University of California, Los Angeles, California, USA.
Karlsberg
Ronald
R
Takano
Yuzuru
Y
Vora
Devandra
D
Tobis
Jonathan
J
D000208:Acute Disease; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D020099:Coated Materials, Biocompatible / Q000009:adverse effects*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D015607:Stents / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications* / Q000000981:diagnostic imaging; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology*; D013997:Time Factors
D000925:Anticoagulants; D020099:Coated Materials, Biocompatible; D006493:Heparin